<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Koren J</submitter><funding>European Structural and Investment Funds</funding><funding>Slovak Research and Development Agency</funding><funding>European Regional Development Fund</funding><pagination>1538</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9686475</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(11)</volume><pubmed_abstract>Carbapenem-resistant (CR) &lt;i>Klebsiella pneumoniae&lt;/i> represents an urgent worldwide threat. We focused on CR &lt;i>K. pneumoniae&lt;/i> in selected facilities of the University Hospital Bratislava (UHB) to investigate sequence types (STs), clonal relatedness, and antimicrobial resistance. Suspected carbapenem-nonsusceptible &lt;i>K. pneumoniae&lt;/i> strains were obtained from hospitalized patients. Further examination included carbapenemase confirmation, cgMLST, and quantitative susceptibility testing. Of the total 41 CR &lt;i>K. pneumoniae&lt;/i> strains, 26 (63.4%) were determined as ST11 in hospital No. 1; of these ST11, 22 (84.6%) were found in the first internal clinic. Six (14.6%) ST258 and three (7.3%) ST584 occurred in hospital No. 2; the most, i.e., four (66.7%), ST258 were detected in the geriatric clinic. In hospital No. 3, we found two (4.8%) ST584 and one (2.4%) ST258. Of the ST11 set, 24 (92.3%) produced NDM-1. Furthermore, seven (87.5) ST258 and five (100%) ST584 strains generated KPC-2. Antimicrobial resistance was as follows: ertapenem 97.6%, meropenem 63.4%, tigecycline 7.3%, eravacycline 7.3%, and colistin 2.5%. We revealed a presumably epidemiological association of ST11 with transmission, particularly in the first internal clinic of hospital No. 1, while ST258 and ST584 were related to interhospital dissemination between medical facilities No. 2 and No. 3. It is essential to prevent the circulation of these pathogens within and between healthcare facilities.</pubmed_abstract><journal>Antibiotics (Basel, Switzerland)</journal><pubmed_title>Next-Generation Sequencing of Carbapenem-Resistant &lt;i>Klebsiella pneumoniae&lt;/i> Strains Isolated from Patients Hospitalized in the University Hospital Facilities.</pubmed_title><pmcid>PMC9686475</pmcid><funding_grant_id>SRDA-20-0413</funding_grant_id><funding_grant_id>ITMS: 313011T431</funding_grant_id><funding_grant_id>NFP313010V344</funding_grant_id><pubmed_authors>Maliar T</pubmed_authors><pubmed_authors>Koren J</pubmed_authors><pubmed_authors>Liptakova A</pubmed_authors><pubmed_authors>Drahovska H</pubmed_authors><pubmed_authors>Hubenakova Z</pubmed_authors><pubmed_authors>Andrezal M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Next-Generation Sequencing of Carbapenem-Resistant &lt;i>Klebsiella pneumoniae&lt;/i> Strains Isolated from Patients Hospitalized in the University Hospital Facilities.</name><description>Carbapenem-resistant (CR) &lt;i>Klebsiella pneumoniae&lt;/i> represents an urgent worldwide threat. We focused on CR &lt;i>K. pneumoniae&lt;/i> in selected facilities of the University Hospital Bratislava (UHB) to investigate sequence types (STs), clonal relatedness, and antimicrobial resistance. Suspected carbapenem-nonsusceptible &lt;i>K. pneumoniae&lt;/i> strains were obtained from hospitalized patients. Further examination included carbapenemase confirmation, cgMLST, and quantitative susceptibility testing. Of the total 41 CR &lt;i>K. pneumoniae&lt;/i> strains, 26 (63.4%) were determined as ST11 in hospital No. 1; of these ST11, 22 (84.6%) were found in the first internal clinic. Six (14.6%) ST258 and three (7.3%) ST584 occurred in hospital No. 2; the most, i.e., four (66.7%), ST258 were detected in the geriatric clinic. In hospital No. 3, we found two (4.8%) ST584 and one (2.4%) ST258. Of the ST11 set, 24 (92.3%) produced NDM-1. Furthermore, seven (87.5) ST258 and five (100%) ST584 strains generated KPC-2. Antimicrobial resistance was as follows: ertapenem 97.6%, meropenem 63.4%, tigecycline 7.3%, eravacycline 7.3%, and colistin 2.5%. We revealed a presumably epidemiological association of ST11 with transmission, particularly in the first internal clinic of hospital No. 1, while ST258 and ST584 were related to interhospital dissemination between medical facilities No. 2 and No. 3. It is essential to prevent the circulation of these pathogens within and between healthcare facilities.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T20:58:36.359Z</modification><creation>2025-04-06T08:38:50.918Z</creation></dates><accession>S-EPMC9686475</accession><cross_references><pubmed>36358193</pubmed><doi>10.3390/antibiotics11111538</doi></cross_references></HashMap>